Kiran Mazumdar-Shaw is the founder and Executive Chairperson of Biocon Limited, a global biopharmaceutical company focused on developing and manufacturing affordable, high-quality medicines across generics, biosimilars, and novel biologics. She drives innovation in drug discovery and delivery while prioritizing health equity—making lifesaving treatments accessible to patients globally, particularly addressing diabetes, cancer, and autoimmune diseases. Under her leadership, Biocon has built integrated R&D and manufacturing capabilities to deliver differentiated biopharmaceutical solutions at scale, with a mission to make medicines affordable and accessible to patients everywhere